A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...

“Increased demand for GLP-1 agonists, new biologic drugs, coupled with on-going supply chain reviews by our customers make this an ideal time for this capacity In Albuquerque to come on-line,” Macnabb ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Asthma can cause both short-term and long-term complications that can worsen your ability to breathe, perform daily tasks, or get restful sleep. Treatment may help prevent complications from ...

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological ...

Chemo may onset menopause, especially if you’re at the age of natural menopause. You may or may not see your period return after finishing chemo. Symptoms and treatments are similar to those of ...

After hours: March 19 at 7:57:20 PM EDT Loading Chart for AGEN ...

After hours: March 19 at 7:43:15 PM EDT Loading Chart for PYXS ...

Mar. 17, 2025 — New hope offered by a pharmacy team for treating heart disease by sharing insights into the fundamental process of how the heart is formed in ...